Building on the strengths of previous editions, the Sixth Edition of Modern Pharmacology with Clinical Applications continues to provide an up-to-date and comprehensive textbook for students of pharmacology. Focusing on the clinical application of drugs within a context of the major principles of pharmacology, this text supplies both students and faculty with an introduction to modern pharmacotherapeutics.

Global collaboration is the cornerstone of scientific advancement. Frontiers in Pharmacology has organized a series of special edition Research Topics, with the goal of highlighting the latest advancements in Ethnopharmacology across the globe, showcasing the academic excellence and high-quality work of internationally recognized researchers. These collections aim to shed light on the recent progress made across the entire breadth of the Ethnopharmacology field, and reflect on the future challenges faced by researchers across borders.

Aureolus Theophrastus Bombastus von Hohenheim (1493-1541), commonly called Paracelsus, was both one of the most original medical thinkers of the sixteenth century and was the man who made opium (as laudanum), arsenic, copper sulphate, iron, lead, mercury, potassium sulphate, and sulphur part of the pharmacopoeia. A man of many parts, but a pioneer chemist, Paracelsus can be regarded as the originator of a body of work which was the precursor of chemical pharmacology and therapeutics. To no small extent he stands, therefore, as a father figure of the modern pharmaceutical industry. Today's physician who wants to look at that industry since the days of Paracelsus and weigh the great gains against the problems soon encounters difficulties. To diminish them, this Enquiry approaches its subject from historical principles. This gives increased perspective to questions asked late in the boo- these questions being prompted by medical practice outside the industry and some twenty years of drug development activity within it. In antiquity medicines often seem to have been used as part of magic and primitive man thought disease to be due to supernatural forces which he could influence. The legacy remains - and in trying to sort out what is rational in our use of drugs today we have to separate our small bits of science from the ancient magic and from modern commercial pressures and conditioning.

Учебное пособие представляет собой систематизированную информацию по основным разделам фармакологии: общей фармакологии, нейротропным средствам, средствам, влияющим на функции сердечно-сосудистой, дыхательной и других систем организма, химиотерапевтическим средствам. В пособии даются основные аспекты фармакодинамики и фармакокинетики лекарственных средств, их применения в клинике. Предыдущее издание вышло в 2019 г. Для иностранных студентов учреждений высшего образования по специальностям «Лечебное дело», «Педиатрия».

This trainers guide was borne out of indicative results of needs assessments of medical trainers who are subject specialists but have minimal skills in executing curricula into classroom teaching and learning. The learning material in this guide is designed and developed using principles of problem-based learning. It offers practical suggestions on lesson planning, classroom and laboratory activities and presentation templates applicable to competency training. The development of numerous professional and positive life skills can be attributed to problem-based learning. These skills include; communication, professional values and ethics, teamwork, reflective practice, self-regulation, self-responsibility, self-drive, independent and life-long learning. This guide has been designed to incorporate teaching and learning methods that develop these skills.

Written in an accessible style and consistent format, the bookcovers both the fundamentals and advances in the pharmacology ofcardiovascular drugs, as well as their integrated applications inthe management of individual cardiovascular diseases. • Integrates fundamentals and recentadvances regarding cardiovascular drugs, blending basic andclinical sciences needed to effectively understand and treatcardiovascular diseases • Facilitates understanding of drug actionand mechanism by covering physiology / pathophysiology andpharmacology • Includes guidelines and algorithms forpharmacotherapeutic management of cardiovascular diseases • Uses case presentations and studyquestions to enhance understanding of the material • Serves as a resource for pharmaceuticaland medical students and researchers interested in cardiovascularissues

This book is the first volume of a comprehensive 2-volume book covering modern pharmacological and clinical studies of the most commonly used Chinese herbal drugs. It contains monographs of 250 kinds of the most commonly used Chinese Materia Medica. The information on each herb was compiled by a research specialist active in the scientific investigation of that particular type of herb. The description on each drug includes an introduction (source, character and taste, actions and indications according to traditional Chinese medicine etc.), chemical composition, pharmacology, clinical studies, adverse effects and references. The translation of the book into English was done by qualified professionals in the field and the terms used are consistent with those used in Index Medicus, Chemical Abstracts and Botanical journals.

Ayurvedic Medicine, or Ayurveda, is a traditional Indian health care system. Research into the medicinal plants utilised in Ayurveda is becoming a global endeavour, and large pharmaceutical companies are investing in novel drug discovery from Ayurvedic sources as a number of clinical studies have demonstrated efficacy of natural products from Ayurvedic plant extracts against common ailments such as arthritis and diabetes. Ayurvedic medicine and its components have been well described in the past, but this book represents a comprehensive source on the biochemistry and mechanisms of the pharmacological effects of natural products from Ayurvedic sources. This book is a valuable resource for researchers in natural products and alternative sources of bioactive compounds in drug discovery, as well as pharmaceutical experts and those in industry.